Source link : https://newshealth.biz/health-news/long-term-tofersen-use-may-slow-als-progression-3-year-data-suggest/
(MedPage Today) — Early initiation of tofersen (Qalsody) was associated with a numerically slower decline in people with SOD1 amyotrophic lateral sclerosis (ALS) compared with delayed treatment, according to data from the VALOR trial and its open… Source link : https://www.medpagetoday.com/neurology/generalneurology/119165 Author : Publish date : 2025-12-23 17:46:00 Copyright for syndicated content belongs to the […]
The post Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-23 17:46:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8